Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
Why You Should Retain Waste Management (WM) in Your Portfolio
by Zacks Equity Research
Core operating endeavors and a solid cash position aid Waste Management (WM).
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is being aided by a complete multiyear Business Transformation and a solid cash position.
Here's Why You Should Invest in Booz Allen Hamilton (BAH)
by Zacks Equity Research
Booz Allen Hamilton (BAH) focuses on integrating velocity, leadership and technology in the process of transformation through its VoLT strategy.
Is Cross Country Healthcare (CCRN) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Cross Country Healthcare (CCRN) and CRA International (CRAI) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights Insperity, Cross Country Healthcare and Kforce
by Zacks Equity Research
Insperity, Cross Country Healthcare and Kforce have been highlighted in this Industry Outlook article.
Zacks.com featured highlights American Airlines, Delta Air Lines, CVR Energy, Covenant Logistics Group and Cross Country Healthcare
by Zacks Equity Research
American Airlines, Delta Air Lines, CVR Energy, Covenant Logistics Group and Cross Country Healthcare have been highlighted in this Screen of The Week article.
3 Stocks to Watch From the Promising Staffing Services Industry
by Zacks Equity Research
The Zacks Staffing industry stands to benefit from the resumption of business activities, increased dependency on technology, shift in recruitment patterns within the industry and cost reduction. NSP, CCRN and KFRC are well poised to witness a demand surge.
5 Broker-Favorite Stocks to Bank on as Market Unrest Continues
by Maharathi Basu
Broker-favorite stocks like American Airlines(AAL), Delta (DAL), CVR Energy (CVI), Covenant Logistics (CVLG) and Cross Country Healthcare (CCRN) are worth retaining in your portfolio amid market disruptions.
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cross Country Healthcare, Inc. (CCRN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cross Country (CCRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cross Country Healthcare (CCRN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 11.46% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
What Awaits Cross Country Healthcare (CCRN) in Q3 Earnings?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) third-quarter 2022 earnings and revenues are expected to have increased year over year.
Is Cross Country (CCRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Cross Country (CCRN) possesses solid growth attributes, which could help it handily outperform the market.
Insperity, Inc. (NSP) Q3 Earnings Beat Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 29.47% and 0.90%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Invesco S&P SmallCap Value with Momentum ETF (XSVM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XSVM
Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $36.36 in the latest trading session, marking a +0.72% move from the prior day.
Cross Country Healthcare (CCRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Business Services Stocks Lagging Charles River Associates (CRAI) This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and Cross Country Healthcare (CCRN) have performed compared to their sector so far this year.
Equifax (EFX) Beats on Q3 Earnings, Trims 2022 EPS Guidance
by Zacks Equity Research
Equifax's (EFX) third-quarter 2022 revenues surge year over year. However, earnings decline.
Omnicom's (OMC) Q3 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Omnicom's (OMC) third-quarter 2022 earnings and revenues increase year over year.
ManpowerGroup (MAN) Q3 Earnings Beat Estimates
by Zacks Equity Research
Manpower (MAN) delivered earnings and revenue surprises of 1.38% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare, Inc. (CCRN) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Cross Country (CCRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Best Value Stocks to Buy for October 19th
by Zacks Equity Research
ESEA, CCRN and CBNK made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 19, 2022.
New Strong Buy Stocks for October 19th
by Zacks Equity Research
ARRY, CBNK, TTC, FIBK and CCRN have been added to the Zacks Rank #1 (Strong Buy) List on October 19, 2022.
Here's Why You Should Retain ABM Industries (ABM) Stock Now
by Zacks Equity Research
The 2020 Vision transformational initiative and shareholder-friendly endeavors boost ABM Industries (ABM).